[1]
W. So, S. Pandya, R. Quilitz, and J. Greene, “INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB”, MJHID, vol. 10, no. 1, p. e2018029, May 2018.